Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter Results on May 7, 2008
01 5월 2008 - 8:30PM
Marketwired
SEATTLE, WA will report its first quarter 2008 financial results
before the open of the financial markets on Wednesday, May 7, 2008.
Following the announcement, management will host a conference call
and webcast discussion of the financial results and provide a
general corporate update beginning at 10:30 a.m. Eastern Time /
7:30 a.m. Pacific Time. You may access the live webcast via the
"Events" section found on the homepage of the Company's website at
www.targetedgenetics.com or via telephone at 800.257.7063
(domestic) or 303.262.2125 (international).
Replay Access
Webcast replay will be available for approximately 30 days at
www.targetedgenetics.com; telephone replay will be available
following Wednesday's call at approximately 10:30 a.m. PT through
11:59 p.m. PT, Saturday, June 7, 2008, by calling 800.405.2236
(domestic) or 303.590.3000 (international); pass code
11112898#.
About Targeted Genetics
Targeted Genetics Corporation is a biotechnology company
committed to the development of innovative targeted molecular
therapies for the prevention and treatment of acquired and
inherited diseases with significant unmet medical need. Targeted
Genetics' proprietary Adeno-Associated Virus (AAV) technology
platform allows it to deliver genes that encode proteins to
increase gene function or RNAi to decrease or silence gene
function. Targeted Genetics' product development efforts target
inflammatory arthritis, AIDS prophylaxis, congestive heart failure
and Huntington's disease. To learn more about Targeted Genetics,
visit Targeted Genetics' website at www.targetedgenetics.com.
Investor and Media Contacts: Stacie D. Byars Senior Associate
WeissComm Partners 415.946.1072 Carolyn Wang Senior Associate
WeissComm Partners 415.946.1065
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024